Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ishida

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Chromosomal abnormalities and clonal evolution in multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Future therapeutic strategies for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 9, 2017
OverviewTadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Antibody therapy for multiple myeloma: novel approaches and future perspectives]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Chemotherapy for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2013
[Myeloma therapy(2) Treatment of transplant-ineligible patients]Tadao Ishida
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: II. The Diagnosis of Multiple Myeloma]Tadao Ishida
Japanese Journal of Clinical Oncology|October 18, 2018
Therapeutic antibodies for multiple myelomaTadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Cytogenetic abnormalities in high-risk multiple myeloma]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Complications and managements in treatment of melphalan, prednisone and new agents]Tadao Ishida
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Chromosomal abnormalities and clonal evolution in multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Future therapeutic strategies for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 9, 2017
OverviewTadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Antibody therapy for multiple myeloma: novel approaches and future perspectives]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Chemotherapy for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2013
[Myeloma therapy(2) Treatment of transplant-ineligible patients]Tadao Ishida
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 1, 2018
[Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: II. The Diagnosis of Multiple Myeloma]Tadao Ishida
Japanese Journal of Clinical Oncology|October 18, 2018
Therapeutic antibodies for multiple myelomaTadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Cytogenetic abnormalities in high-risk multiple myeloma]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Complications and managements in treatment of melphalan, prednisone and new agents]Tadao Ishida
Pageof 16